Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adcock LL et al. (1984) Carcinoma of the cervix, FIGO Stage IB: treatment failures. Gynecol Oncol 18:218–225
Au WW, Sierra-Torres CH, Tyring SK (2003) Acquired and genetic susceptibility to cervical cancer. Mutation Res 544:361–364
Belinson JL, Doherty M, McDay JB (1984) A new technique for ovarian transposition. Surg Gynecol Obstet 159:157–160
Bhatnagar JP, Kaplan C, Specht R (1980) A rule of thumb for dose rate at point A for the Fletcher-Suit applicator. Br J Radiol 53:511–512
Chen RJ et al. (1999) Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan. Gynecol Oncol 73:184–190
Coia L et al. (1990) The patterns of care outcome study for cancer of the uterine cervix. Results of the Second National Practice Survey. Cancer 66:2451–2456
Committee on Practice (2002) B.-G., ACOG practice bulletin. Diagnosis and treatment of cervical carcinomas, number 35, May 2002. Obstet Gynecol 99:855–867
Cosin JA et al. (1998) Pretreatment surgical staging of patients with cervical carcinoma: the case for lymph node debulking. Cancer 82:2241–2248
Crook JM et al. (1987) Dose-volume analysis and the prevention of radiation sequelae in cervical cancer. Radiother Oncol 8:321–332
Deore SM et al. (1991) The severity of late rectal and rectosigmoid complications related to fraction size in irradiation treatment of carcinoma cervix stage III B. Strahlenther Onkol 167:638–642
Dunleavey R (2004) Incidence, pathophysiology and treatment of cervical cancer. Nursing Times 100:38–41
Dunst J et al. (2003) Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis. Int J Radiation Oncol Biol Phys 56:778–787
Eifel PJ et al. (1990) Adenocarcinoma of the uterine cervix. Prognosis and patterns of failure in 367 cases. Cancer 65:2507–2514
Eifel PJ et al. (1995) Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 32:1289–1300
Erridge SC et al. (2002) The effect of overall treatment time on the survival and toxicity of radical radiotherapy for cervical carcinoma. Radiother Oncol 63:59–66
Esche BA et al. (1987) Reference volume, milligram-hours and external irradiation for the Fletcher applicator. Radiother Oncol. 9:255–261
Fey MC and Beal MW (2004) Role of human papilloma virus testing in cervical cancer prevention. J Midwifery Women’s Health 49:4–13
Fletcher GH (1973) Female pelvis: squamous cell carcinoma of the uterine cervix. In: Fletcher GH (ed) Textbook of radiotherapy. Saunders, London, p 620
Gasinska A et al. (2002) Prognostic significance of intratumour microvessel density and haemoglobin level in carcinoma of the uterine cervix. Acta Oncologica 41:437–443
Gerbaulet AL et al. (1992) Combined radiotherapy and surgery: local control and complications in early carcinoma of the uterine cervix-the Villejuif experience, 1975–1984. Radiother Oncol 23:66–73
Ghosh K et al. (2001) Using a belly board device to reduce the small bowel volume within pelvic radiation fields in women with postoperatively treated cervical carcinoma. Gynecol Oncol 83:271–275
Greven K et al. (1999) Current developments in the treatment of newly diagnosed cervical cancer. Hematol Oncol Clin North Am 13:275–303
Grigsby PW et al. (2001) Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys 51: 982–987
Grigsby PW et al. (2004) Posttherapy [18F] fluorodeoxy-glucose positron emission tomography in carcinoma of the cervix: response and outcome. J Clin Oncol 22:2167–2171
Hanks GE, Herring DF, Kramer S (1983) Patterns of care outcome studies. Results of the national practice in cancer of the cervix. Cancer 51:959–967
Harima Y et al. (2002) Human papilloma virus (HPV) DNA associated with prognosis of cervical cancer after radiotherapy. Int J Radiat Oncol Biol Phys 52:1345–1351
Hernandez-Hernandez DM et al. (2003) Association between high-risk human papillomavirus DNA load and precursor lesions of cervical cancer in Mexican women. Gynecol Oncol 90:310–317
Herzog TJ (2003) New approaches for the management of cervical cancer. Gynecol Oncol 90:S22–S27
Horiot JC et al. (1988) Radiotherapy alone in carcinoma of the intact uterine cervix according to G.H. Fletcher guidelines: a French cooperative study of 1383 cases. Int J Radiat Oncol Biol Phys 14:605–611
Husseinzadeh N et al. (1984) The preservation of ovarian function in young women undergoing pelvic radiation therapy. Gynecol Oncol 18:373–379
ICRU (1985) Dose and volume specification for reporting intracavitary therapy in gynecology. ICRU Report 38:1
Jhingran A, Eifel PJ (2000) Perioperative and postoperative complications of intracavitary radiation for FIGO stage IIII carcinoma of the cervix. Int J Radiat Oncol Biol Phys 46:1177–1183
Karolewski K et al. (1999) Prognostic significance of pretherapeutic and therapeutic factors in patients with advanced cancer of the uterine cervix treated with radical radiotherapy alone. Acta Oncologica 38:461–468
Katz A, Eifel PJ (2000) Quantification of intracavitary brachytherapy parameters and correlation with outcome in patients with carcinoma of the cervix (see comment). Int J Radiat Oncol Biol Phys 48:1417–1425
Keys HM et al. (1999) Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340:1154–1161
Kim RY et al. (1989) Radiation alone in the treatment of cancer of the uterine cervix: analysis of pelvic failure and dose response relationship. Int J Radiat Oncol Biol Phys 17:973–978
Kramer C et al. (1989) Radiation treatment of FIGO stage IVA carcinoma of the cervix. Gynecol Oncol 32:323–326
Kucera H et al. (1986) Prognosis of primary radiotherapy of cervix cancer in younger females (in German). Geburtshilfe Frauenheilkd 46:800–803
Kucera H et al. (1987) The influence of nicotine abuse and diabetes mellitus on the results of primary irradiation in the treatment of carcinoma of the cervix. Cancer 60:1–4
Kutcher GJ et al. (1994) Comprehensive QA for radiation oncology: report of AAPM Radiation Therapy Committee Task Group 40. Med Phys 21:581–618
Landoni F et al. (1997) Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer (see comment). Lancet 350:535–540
Leibel S et al. (1987) Radiotherapy with or without misonidazole for patients with stage IIIB or stage IVA squamous cell carcinoma of the uterine cervix: preliminary report of a Radiation Therapy Oncology Group randomized trial. Int J Radiat Oncol Biol Phys 13:541–549
Lieu D (1996) The Papanicolaou smear: its value and limitations (see comment). J Fam Pract 42:391–399
Lukka H et al. (2002) Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer — a meta-analysis (see comment). Clin Oncol (Royal College of Radiologists) 14:203–212
Mashburn J, Scharbo-DeHaan M (1997) A clinician’s guide to Pap smear interpretation (see comment). Nurse Practitioner 22:115–118
Mendenhall WM et al. (1984) Prognostic and treatment factors affecting pelvic control of Stage IB and IIA-B carcinoma of the intact uterine cervix treated with radiation therapy alone. Cancer 53:2649–2654
Montana GS, Fowler WC (1989) Carcinoma of the cervix: analysis of bladder and rectal radiation dose and complications. Int J Radiat Oncol Biol Phys 16:95–100
Montana GS et al. (1983) Carcinoma of the cervix stage IB: results of treatment with radiation therapy. Int J Radiat Oncol Biol Phys 9:45–49
Montana GS et al. (1985) Analysis of results of radiation therapy for stage II carcinoma of the cervix. Cancer 55:956–962
Montana GS et al. (1986) Carcinoma of the cervix, stage III. Results of radiation therapy. Cancer 57:148–154
Montana GS et al. (1987) Analysis of results of radiation therapy for stage IB carcinoma of the cervix. Cancer 60:2195–2200
Montana GS, Martz KL, Hanks GE (1991) Patterns and sites of failure in cervix cancer treated in the U.S.A. in 1978. Int J Radiat Oncol Biol Phys 20:87–93
Mutic S et al. (2003) PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes — a dose-escalation treatment planning study. Int J Radiat Oncol Biol Phys 55:28–35
Nag S et al. (1999) The American brachytherapy society survey of brachytherapy practice for carcinoma of the cervix in the United States. Gynecol Oncol 73:111–118
Nag S et al. (2002) The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix (see comment). Int J Radiat Oncol Biol Phys 52:33–48 (erratum 52:1157)
Orton CG (1998) High and low dose-rate brachytherapy for cervical carcinoma. Acta Oncol 37:117–125
Perez CA et al. (1984) Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications. Cancer 54:235–246
Perez CA et al. (1998) Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. Int J Radiat Oncol Biol Phys 41:307–317
Perez CA et al. (1999) Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys 44:855–866
Perlman SE (1999) Pap smears: screening, interpretation, treatment. Adolescent Medicine State of the Art Reviews 10:243–254
Peters WA, 3rd, et al. (2000) Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18:1606–1613
Potish RA (1992) Cervix cancer. In: Lewitt SH (ed) Technological basis of radiation therapy. Lea & Febiger, Philadelphia, p 289
Potish RA, Gerbi BJ (1986) Role of point A in the era of computerized dosimetry. Radiology 158:827–831
Potish RA, Twiggs LB (1989) An analysis of adjuvant treatment strategies for carcinoma of the cervix. Am J Clin Oncol 12:430–433
Potish RA, Deibel FC Jr., Khan FM (1982) The relationship between milligram-hours and dose to point A in carcinoma of the cervix. Radiology 145:479–483
Potish RA et al. (1984) The utility and limitations of decision theory in the utilization of surgical staging and extended field radiotherapy in cervical cancer. Obstet Gynecol Surv 39:555–562
Potish RA et al. (1989) The role of surgical debulking in cancer of the uterine cervix. Int J Radiat Oncol Biol Phys 17:979–984
Pourquier H et al. (1987) A quantified approach to the analysis and prevention of urinary complications in radiotherapeutic treatment of cancer of the cervix. Int J Radiat Oncol Biol Phys 13:1025–1033
Rose PG et al. (1999) Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340:1144–1153
Sasaoka M et al. (2001) Patterns of failure in carcinoma of the uterine cervix treated with definitive radiotherapy alone. Am J Clin Oncol 24:586–590
Sedlis A et al. (1999) A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study (see comment). Gynecol Oncol 73:177–183
Singh AK et al. (2003) FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma. Int J Radiat Oncol Biol Phys 56:489–493
Sommers GM et al. (1989) Outcome of recurrent cervical carcinoma following definitive irradiation. Gynecol Oncol 35:150–155
Thoms WW Jr., et al. (1992) Bulky endocervical carcinoma: a 23-year experience. Int J Radiat Oncol Biol Phys 23:491–499
Tsai CS et al. (2004) Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT. Int J Radiat Oncol Biol Phys 58:1506–1512
Unal A et al. (1981) An analysis of the severe complications of irradiation of carcinoma of the uterine cervix: treatment with intracavitary radium and parametrial irradiation. Int J Radiat Oncol Biol Phys 7:999–1004
Waggoner SE (2003) Cervical cancer. Lancet 361:2217–2225
Whitney CW et al. (1999) Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17:1339–1348
Willen H et al. (1985) Invasive squamous cell carcinoma of the uterine cervix. VIII. Survival and malignancy grading in patients treated by irradiation in Lund 1969–1970. Acta Radiol Oncol 24:41–50
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Dusenbery, K.E., Gerbi, B.J. (2006). Radiation Therapy for Cervical Cancer. In: Levitt, S.H., Purdy, J.A. (eds) Technical Basis of Radiation Therapy. Medical Radiology. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-35665-7_24
Download citation
DOI: https://doi.org/10.1007/3-540-35665-7_24
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-21338-3
Online ISBN: 978-3-540-35665-3
eBook Packages: MedicineMedicine (R0)